Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Eli Lilly Gains Slightly on Dulaglutide Data
Yahoo/Zacks.com
Thu, 02/27/14 - 04:56 pm
Tags:
Eli Lilly, dulaglutide, diabetes
Who loses most in Lilly vs. Novo diabetes study? AstraZeneca
Fierce Pharma
Wed, 02/26/14 - 07:02 pm
Tags:
Victoza, Novo Nordisk, Eli Lilly, dulaglutide, diabetes, Bydureon, AstraZeneca
Clock Is Ticking For AstraZeneca
Forbes
Tue, 02/25/14 - 03:57 pm
Tags:
AstraZeneca, dulaglutide, GSK, Eli Lilly, Bydureon, diabetes
Lilly weekly diabetes drug succeeds vs market leader Victoza -study
Yahoo/Reuters
Tue, 02/25/14 - 08:15 am
Tags:
Eli Lilly, diabetes, Victoza, Novo Nordisk, dulaglutide
Public Citizen says FDA should add heart warning to popular testosterone drugs for men
Yahoo/AP
Tue, 02/25/14 - 07:27 am
Tags:
FDA, testosterone, Public Citizen, Androgel, Androderm, Fortesta, Axiron, Watson Pharmaceuticals, AbbVie, Eli Lilly, Endo Health Solutions
5 Pharmas Spending the Most to Develop Drugs: Merck, AstraZeneca, Roche, Bristol, and Lilly
Motley Fool
Tue, 02/25/14 - 07:22 am
Tags:
Merck, AstraZeneca, Roche, Bristol-Myers Squibb, Eli Lilly, R&D, drug development
Attack On Lung Cancer: Eli Lilly Vs. Rivals
Seeking Alpha
Mon, 02/24/14 - 09:53 am
Tags:
Eli Lilly, non-small cell lung cancer, Roche, ramucirumab, Sanofi
Lilly Agrees to Buy Animal Health Firm, Cuts Outlook
Marketwatch
Mon, 02/24/14 - 09:00 am
Tags:
M&A, animal health, Eli Lilly, Elanco, Lohmann SE
Eli Lilly's Ramucirumab for lung cancer meets Phase III survival endpoint
Yahoo/Fly on the Wall
Wed, 02/19/14 - 08:41 am
Tags:
Eli Lilly, ramucirumab, non-small cell lung cancer
Poor Pipeline Management Imperils Lilly's Future Cash Flows
Motley Fool
Mon, 02/17/14 - 03:22 pm
Tags:
Eli Lilly, diabetes, insulin, Novo Nordisk, Sanofi, oncology, Alzheimer's disease
Can drug makers find profit in collaboration?
Forbes
Tue, 02/11/14 - 04:45 pm
Tags:
NIH, Bristol-Myers Squibb, Pfizer, GSK, Eli Lilly, Merck, Amgen
Big Pharma Diversification: A Winning Model or Recipe for Disaster?
Motley Fool
Tue, 02/11/14 - 12:03 pm
Tags:
Big Pharma, diversification, Merck, Eli Lilly, AbbVie, Abbott Laboratories, Pfizer
What's Big Pharma's latest hot spot? The Middle East
Fierce Pharma
Tue, 02/11/14 - 12:00 pm
Tags:
Middle East, Merck, Merck Serono, Sanofi, Novo Nordisk, Eli Lilly, Bayer
The Effects Of Copycat Drugs on Novartis, Merck, and Eli Lilly
Motley Fool
Sat, 02/8/14 - 12:49 pm
Tags:
Eli Lilly, Novartis, Merck, generics
Could These Potential Catalysts Drive Lilly Higher?
Motley Fool
Tue, 02/4/14 - 06:58 pm
Tags:
Eli Lilly, Evista, Zyprexa, Cymbalta, generics, solanezumab, Alzheimer's disease, LY2963016, diabetes, empagliflozin, dulaglutide
Sanofi sues Eli Lilly over patents for top-selling insulin drug
Yahoo/Reuters
Fri, 01/31/14 - 08:06 am
Tags:
Sanofi, Eli Lilly, insulin, diabetes, Lantus
Lilly Tops Earnings Estimates Despite Loss of Top Drug
Bloomberg
Thu, 01/30/14 - 10:04 am
Tags:
earnings, Eli Lilly
Earnings Preview: Lilly pipeline comments anticipated in Q4 report
The Fly on the Wall
Wed, 01/29/14 - 02:54 pm
Tags:
Eli Lilly, earnings
Ariad Pharma Short Seller Explains Why Takeover Rumor is Bunk
TheStreet.com
Mon, 01/27/14 - 12:20 pm
Tags:
Ariad Pharmaceuticals, M&A, AP26113, Eli Lilly, Iclusig
This Week in Biotech: Clinical Success, Plus Wheeling and Dealing
Motley Fool
Sun, 01/26/14 - 10:46 am
Tags:
BioDelivery Sciences, Endo Health Solutions, Karyopharm Therapeutics, Repligen, Biomarin, Ariad Pharmaceuticals, Eli Lilly, GSK, Shire

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.